Lataa...
A fatal case of bupropion (Zyban) hepatotoxicity with autoimmune features: Case report
BACKGROUND: Bupropion is approved for the treatment of mood disorders and as an adjuvant medication for smoking cessation. Bupropion is generally well tolerated and considered safe. Two randomized controlled trials of bupropion therapy for smoking cessation did not report any hepatic adverse events....
Tallennettuna:
| Päätekijät: | , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BioMed Central
2007
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2008202/ https://ncbi.nlm.nih.gov/pubmed/17877816 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1752-1947-1-88 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|